This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsMusclePharm（MSLP.Q）株式概要マッスルファーム・コーポレーションは、スポーツ栄養製品および栄養補助食品を開発、製造、販売し、米国内外で販売している。 詳細MSLP.Q ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金0/6リスク分析最新の財務報告は1年以上前のものである 意味のある時価総額がありません ( $33 )株式の流動性は非常に低い すべてのリスクチェックを見るMSLP.Q Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.000001100.0% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-51m169m2016201920222025202620282031Revenue US$50.0mEarnings US$4.9mAdvancedSet Fair ValueView all narrativesMusclePharm Corporation 競合他社LifeQuest WorldSymbol: OTCPK:LQWCMarket cap: US$1.3mNevis BrandsSymbol: OTCPK:NEVI.FMarket cap: US$840.8kCyanotechSymbol: OTCPK:CYANMarket cap: US$3.8mPeregrine IndustriesSymbol: OTCPK:PGIDMarket cap: US$126.1k価格と性能株価の高値、安値、推移の概要MusclePharm過去の株価現在の株価US$0.00000152週高値US$0.00002552週安値US$0.000001ベータ01ヶ月の変化0%3ヶ月変化0%1年変化n/a3年間の変化-100.00%5年間の変化-100.00%IPOからの変化-100.00%最新ニュースお知らせ • Sep 29FitLife Brands, Inc. (NasdaqCM:FTLF) entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.FitLife Brands, Inc. (NasdaqCM:FTLF) entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million on September 5, 2023. The Purchase Price is subject to adjustment and is expected to be funded from available cash and the proceeds from a committed $10.0 million term loan from First Citizens Bank with an interest rate equal to the SOFR (secured overnight financing rate) plus 275 basis points. On September 21, 2023, the U.S. Bankruptcy Court for the District of Nevada approved the transaction. Closing of the sale will occur on or before October 16, 2023. Samuel A. Schwartz of Schwartz Law, PLLC acted as legal advisor to MusclePharm. Todd Feinsmith of Troutman Pepper Hamilton Sanders LLP acted as legal advisor to FitLife Brands.お知らせ • Sep 01Musclepharm Corporation Announces Resignation of Paul Karr as DirectorEffective as of August 9, 2023, Paul Karr resigned as director MusclePharm Corporation. Mr. Karr’s resignation from the Board of Directors of the Company did not result from any disagreement with the Company.お知らせ • Jul 22Musclepharm Corporation Terminates Gary Shirshac as Chief Financial OfficerEffective as of July 10, 2023, MusclePharm Corporation terminated Chief Financial Officer, Gary Shirshac. There are no family relationships between Mr. Shirshac and any other director or officer of the Company. There are no transactions in which Mr. Shirshac has an interest requiring disclosure under Item 404(a) of Regulation S-K. Separately, on December 15, 2022, the Company filed for protection under Chapter 11 of the United States Bankruptcy Code before the United States Bankruptcy Court for the District of Nevada, Case No. 22-14422 – NMC. Attached hereto are copies of the Monthly Operating Reports filed in the bankruptcy case.お知らせ • Dec 16MusclePharm Corporation Filed for BankruptcyMusclePharm Corporation filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Nevada on December 15, 2022. The debtor listed both its assets and liabilities in the range of $10 million to $50 million. The debtor is represented by Samuel A. Schwartz of Schwartz Law, PLLC as its legal counsel.お知らせ • Sep 30MusclePharm Corporation Appoints Gary C. Shirshac to Serve as Interim Chief Financial OfficerOn September 26, 2022, MusclePharm Corporation appointed Gary C. Shirshac to serve as interim chief financial officer. There are no family relationships between Mr. Shirshac and any other director or officer of the company. There are no transactions in which Mr. Shirshac has an interest requiring disclosure under Item 404(a) of Regulation S-K. Set forth below is the biographical information of Mr. Shirshac, as required by Item 401 of Regulation S-K. Mr. Shirshac’s base salary is $250,000 and he will be eligible to participate in the company’s benefits plan as of October 1, 2022. Prior to joining the company, Mr. Shirshac, 60, served as the chief financial officer and on the board of Directors of Newpoint Financial Corporation from 2020 to February 2022. Prior to that, Mr. Shirshac served as the Chief Financial Officer and Managing Director of GCS Consulting from 2013 to 2019. Mr. Shirshac’s work experience prior to that included accounting, tax and SEC compliance work in-house, as a consultant and in national accounting firms. Mr. Shirshac is a Certified Public Accountant and received his BS Accountancy from Villanova University.お知らせ • Aug 18MusclePharm Corporation announced delayed 10-Q filingOn 08/17/2022, MusclePharm Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.最新情報をもっと見るRecent updatesお知らせ • Sep 29FitLife Brands, Inc. (NasdaqCM:FTLF) entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.FitLife Brands, Inc. (NasdaqCM:FTLF) entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million on September 5, 2023. The Purchase Price is subject to adjustment and is expected to be funded from available cash and the proceeds from a committed $10.0 million term loan from First Citizens Bank with an interest rate equal to the SOFR (secured overnight financing rate) plus 275 basis points. On September 21, 2023, the U.S. Bankruptcy Court for the District of Nevada approved the transaction. Closing of the sale will occur on or before October 16, 2023. Samuel A. Schwartz of Schwartz Law, PLLC acted as legal advisor to MusclePharm. Todd Feinsmith of Troutman Pepper Hamilton Sanders LLP acted as legal advisor to FitLife Brands.お知らせ • Sep 01Musclepharm Corporation Announces Resignation of Paul Karr as DirectorEffective as of August 9, 2023, Paul Karr resigned as director MusclePharm Corporation. Mr. Karr’s resignation from the Board of Directors of the Company did not result from any disagreement with the Company.お知らせ • Jul 22Musclepharm Corporation Terminates Gary Shirshac as Chief Financial OfficerEffective as of July 10, 2023, MusclePharm Corporation terminated Chief Financial Officer, Gary Shirshac. There are no family relationships between Mr. Shirshac and any other director or officer of the Company. There are no transactions in which Mr. Shirshac has an interest requiring disclosure under Item 404(a) of Regulation S-K. Separately, on December 15, 2022, the Company filed for protection under Chapter 11 of the United States Bankruptcy Code before the United States Bankruptcy Court for the District of Nevada, Case No. 22-14422 – NMC. Attached hereto are copies of the Monthly Operating Reports filed in the bankruptcy case.お知らせ • Dec 16MusclePharm Corporation Filed for BankruptcyMusclePharm Corporation filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Nevada on December 15, 2022. The debtor listed both its assets and liabilities in the range of $10 million to $50 million. The debtor is represented by Samuel A. Schwartz of Schwartz Law, PLLC as its legal counsel.お知らせ • Sep 30MusclePharm Corporation Appoints Gary C. Shirshac to Serve as Interim Chief Financial OfficerOn September 26, 2022, MusclePharm Corporation appointed Gary C. Shirshac to serve as interim chief financial officer. There are no family relationships between Mr. Shirshac and any other director or officer of the company. There are no transactions in which Mr. Shirshac has an interest requiring disclosure under Item 404(a) of Regulation S-K. Set forth below is the biographical information of Mr. Shirshac, as required by Item 401 of Regulation S-K. Mr. Shirshac’s base salary is $250,000 and he will be eligible to participate in the company’s benefits plan as of October 1, 2022. Prior to joining the company, Mr. Shirshac, 60, served as the chief financial officer and on the board of Directors of Newpoint Financial Corporation from 2020 to February 2022. Prior to that, Mr. Shirshac served as the Chief Financial Officer and Managing Director of GCS Consulting from 2013 to 2019. Mr. Shirshac’s work experience prior to that included accounting, tax and SEC compliance work in-house, as a consultant and in national accounting firms. Mr. Shirshac is a Certified Public Accountant and received his BS Accountancy from Villanova University.お知らせ • Aug 18MusclePharm Corporation announced delayed 10-Q filingOn 08/17/2022, MusclePharm Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jul 29+ 1 more updateMusclePharm Corporation Announces Appointment of Eric Chin as Chief Financial Officer of the CompanyMusclePharm Corporation announced that on July 28, 2022, the Board of Directors appointed Eric Chin as Chief Financial Officer of the Company. There are no family relationships between Mr. Chin and any other director or officer of the Company. Mr. Chin, joined the Company in June 2022 as Chief Accounting Officer. Prior to that, Mr. Chin served as the Chief Financial Officer of Apollo Medical Holdings Inc. from 2018 to May 2022. Prior to that, Mr. Chin served as the Controller/Head of Finance - Real Estate of Public Storage from 2015 to 2018. Mr. Chin served as Assistant Vice-President - Financial Reporting of Alexandria Real Estate Equities Inc. from 2011 to 2015. Mr. Chin began his career at Ernst & Young, LLP in 2002. Mr. Chin is a Certified Public Accountant and received his Bachelor of Arts in Business/Economics with Accounting and Computing from UCLA.お知らせ • Jul 13+ 1 more updateSabina Rizvi Notifies MusclePharm Corporation of Her Resignation as President, Effective July 22, 2022On July 6, 2022, Sabina Rizvi notified the Board of Directors of MusclePharm Corporation of her resignation as President of the Company, effective July 22, 2022.お知らせ • Jul 07MusclePharm Announces the Launch of FitMiss EnergyMusclePharm Corporation announced the launch of FitMiss Energy, a ready-to-drink, zero-calorie functional energy beverage featuring 450mg of Branched Chain Amino Acids (“BCAA”), 200mg of caffeine, and 100% recommended dietary intake (“RDI”) of Biotin per can in three refreshing flavors: Pineapple Coco, Mango Sunshine, and Watermelon Waterfall. The MusclePharm FitMiss brand has been a leader in the female performance segment, with FitMiss Delight, for the last 5 years. Building onto the FitMiss brand family, FitMiss Energy features no artificial colorings or flavorings and is available in competitively priced, 12-can cases of a single flavor or a variety-pack format exclusively on Amazon.お知らせ • Jun 24Musclepharm Corporation Appoints Eric Chin as Chief Accounting OfficerMusclePharm Corporation announced that effective as of June 17, 2022 the company appointed Mr. Eric Chin as the Company’s Chief Accounting Officer. Mr. Chin, age 42, joins the Company from Apollo Medical Holdings Inc., where he served as Chief Financial Officer. From 2015 to 2018, Mr. Chin served as the Controller/Head of Finance - Real Estate of Public Storage. From 2011 to 2015, he served as Assistant Vice-President - Financial Reporting of Alexandria Real Estate Equities Inc. Mr. Chin began his career at Ernst & Young, LLP in 2002. Mr. Chin is a Certified Public Accountant. He received his Bachelor of Arts in Business/Economics with Accounting and Computing from UCLA.お知らせ • Jun 15MusclePharm Corporation Appoints Sabina Rizvi as Member of the Board of DirectorsMusclePharm Corporation announced that effective June 10, 2022, the company appointed Sabina Rizvi, the Company’s President and Chief Financial Officer, as a member of the board of directors of the Company. Sabina Rizvi has served as the Company’s President and Chief Financial Officer since April 2021. Previously, Ms. Rizvi held multiple C-suite roles at Yum! Brands, with increasing responsibility including CFO of the Canadian and Thailand business units and President and General Manager of Pizza Hut Thailand, where she oversaw significant growth of the brand. Most recently, she was Chief Operating Officer, Yum! Digital and Technology, playing an instrumental role in leveraging technology to transform the customer experience. Ms. Rizvi graduated from University of Windsor, Canada with a Master of Business Administration and completed her Honors Bachelor of Mathematics from University of Waterloo, Canada. The Company believes Ms. Rizvi is qualified to serve as a member of the Company’s board of directors because of the aforementioned experience and the breadth of her management responsibilities with the Company.お知らせ • May 12MusclePharm Corporation to Report Q1, 2022 Results on May 16, 2022MusclePharm Corporation announced that they will report Q1, 2022 results After-Market on May 16, 2022お知らせ • Apr 13MusclePharm Corporation to Report Q4, 2021 Results on Apr 14, 2022MusclePharm Corporation announced that they will report Q4, 2021 results After-Market on Apr 14, 2022お知らせ • Apr 01+ 1 more updateMusclePharm Corporation announced delayed annual 10-K filingOn 03/31/2022, MusclePharm Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Feb 08MusclePharm Rolls Out New and Improved MP Combat Protein Powder to Costco USMusclePharm Corporation announced the expansion of its product line with Costco U.S with the roll out of its reformulated MP Combat Protein Powder in a newly sized tub. The reformulated product has an improved taste and mixability factor and is now being sold in Costco U.S in a recyclable, 6.2-liter tub. The new product will be part of a promotion running in all Costco U.S stores this March with samples available for customers to try out the new taste.お知らせ • May 18MusclePharm Corporation announced delayed 10-Q filingOn 05/17/2021, MusclePharm Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jan 22Musclepharm Appoints Michael Heller to Its Board of DirectorsMusclePharm Corporation announced that it has appointed Michael Heller to its Board of Directors. Michael Heller, Principal of Talent Resources Holdings, is a marketing visionary in the world of influencer, celebrity, athlete and social media marketing. He has become a leading industry voice, having appeared in such major outlets as CNBC, Business Insider, Fortune, Fox Business, Buzzfeed, CNN, Digiday, The Hollywood Reporter, Vanity Fair and many others. With over 25 years of experience, Michael has conceived and produced some of the most high-profile events and activations in the country, including the annual Sports Illustrated Super Bowl party.お知らせ • Jan 09William Bush Submits Resignation from the Board of Directors of MusclePharm Corporation and All CommitteesOn December 31, 2020, William Bush submitted his resignation from the Board of Directors of MusclePharm Corporation and all committees on which he served, effective the date thereof.株主還元MSLP.QUS Personal ProductsUS 市場7D0%4.9%1.1%1Yn/a-15.2%28.7%株主還元を見る業界別リターン: MSLP.QがUS Personal Products業界に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。リターン対市場: MSLP.Q US市場に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。価格変動Is MSLP.Q's price volatile compared to industry and market?MSLP.Q volatilityMSLP.Q Average Weekly Movementn/aPersonal Products Industry Average Movement7.9%Market Average Movement7.2%10% most volatile stocks in US Market16.5%10% least volatile stocks in US Market3.1%安定した株価: MSLP.Qの株価は、 US市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のMSLP.Qのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト2006n/aEric Hillmanwww.musclepharm.comマッスルファーム・コーポレーションは、スポーツ栄養製品および栄養サプリメントを開発、製造、販売し、米国内外で販売している。同社は様々なパフォーマンスパウダー、カプセル、タブレット、ジェル、持ち運び可能なスナック菓子などを提供している。マッスルファーム・ブランドの製品ポートフォリオには、コンバット・プロテイン・パウダーやコンバット・クランチ・プロテイン・バー、BCAA、クレアチン、グルタミン、カルニチン、CLA、フィッシュオイル、マルチビタミンなどの必須サプリメントなどがある。同社はまた、FitMissブランドのスポーツ栄養製品も提供している。これは主に女性の体のために処方され、体重管理、除脂肪体重、体組成、一般的な健康とウェルネスの分野で女性をサポートするもので、Combat EnergyとFitMiss Energyブランドの機能性エネルギー飲料も提供している。同社は様々なアスリートやフィットネス愛好家に製品を販売している。同社は2006年に法人化され、ネバダ州ラスベガスを拠点としている。2022年12月15日、マッスルファーム・コーポレーションはネバダ州連邦破産裁判所に連邦破産法第11条に基づく任意整理を申請した。もっと見るMusclePharm Corporation 基礎のまとめMusclePharm の収益と売上を時価総額と比較するとどうか。MSLP.Q 基礎統計学時価総額US$33.00収益（TTM）-US$19.26m売上高(TTM)US$50.02m0.0xP/Sレシオ0.0xPER（株価収益率MSLP.Q は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計MSLP.Q 損益計算書（TTM）収益US$50.02m売上原価US$46.83m売上総利益US$3.19mその他の費用US$22.45m収益-US$19.26m直近の収益報告Mar 31, 2022次回決算日該当なし一株当たり利益（EPS）0グロス・マージン0.00%純利益率0.00%有利子負債／自己資本比率0.0%MSLP.Q の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2025/03/08 19:44終値2025/03/05 00:00収益2022/03/31年間収益2021/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋MusclePharm Corporation 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Edward WooAscendiant Capital Markets LLCJack WallaceSidoti & Company, LLC
お知らせ • Sep 29FitLife Brands, Inc. (NasdaqCM:FTLF) entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.FitLife Brands, Inc. (NasdaqCM:FTLF) entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million on September 5, 2023. The Purchase Price is subject to adjustment and is expected to be funded from available cash and the proceeds from a committed $10.0 million term loan from First Citizens Bank with an interest rate equal to the SOFR (secured overnight financing rate) plus 275 basis points. On September 21, 2023, the U.S. Bankruptcy Court for the District of Nevada approved the transaction. Closing of the sale will occur on or before October 16, 2023. Samuel A. Schwartz of Schwartz Law, PLLC acted as legal advisor to MusclePharm. Todd Feinsmith of Troutman Pepper Hamilton Sanders LLP acted as legal advisor to FitLife Brands.
お知らせ • Sep 01Musclepharm Corporation Announces Resignation of Paul Karr as DirectorEffective as of August 9, 2023, Paul Karr resigned as director MusclePharm Corporation. Mr. Karr’s resignation from the Board of Directors of the Company did not result from any disagreement with the Company.
お知らせ • Jul 22Musclepharm Corporation Terminates Gary Shirshac as Chief Financial OfficerEffective as of July 10, 2023, MusclePharm Corporation terminated Chief Financial Officer, Gary Shirshac. There are no family relationships between Mr. Shirshac and any other director or officer of the Company. There are no transactions in which Mr. Shirshac has an interest requiring disclosure under Item 404(a) of Regulation S-K. Separately, on December 15, 2022, the Company filed for protection under Chapter 11 of the United States Bankruptcy Code before the United States Bankruptcy Court for the District of Nevada, Case No. 22-14422 – NMC. Attached hereto are copies of the Monthly Operating Reports filed in the bankruptcy case.
お知らせ • Dec 16MusclePharm Corporation Filed for BankruptcyMusclePharm Corporation filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Nevada on December 15, 2022. The debtor listed both its assets and liabilities in the range of $10 million to $50 million. The debtor is represented by Samuel A. Schwartz of Schwartz Law, PLLC as its legal counsel.
お知らせ • Sep 30MusclePharm Corporation Appoints Gary C. Shirshac to Serve as Interim Chief Financial OfficerOn September 26, 2022, MusclePharm Corporation appointed Gary C. Shirshac to serve as interim chief financial officer. There are no family relationships between Mr. Shirshac and any other director or officer of the company. There are no transactions in which Mr. Shirshac has an interest requiring disclosure under Item 404(a) of Regulation S-K. Set forth below is the biographical information of Mr. Shirshac, as required by Item 401 of Regulation S-K. Mr. Shirshac’s base salary is $250,000 and he will be eligible to participate in the company’s benefits plan as of October 1, 2022. Prior to joining the company, Mr. Shirshac, 60, served as the chief financial officer and on the board of Directors of Newpoint Financial Corporation from 2020 to February 2022. Prior to that, Mr. Shirshac served as the Chief Financial Officer and Managing Director of GCS Consulting from 2013 to 2019. Mr. Shirshac’s work experience prior to that included accounting, tax and SEC compliance work in-house, as a consultant and in national accounting firms. Mr. Shirshac is a Certified Public Accountant and received his BS Accountancy from Villanova University.
お知らせ • Aug 18MusclePharm Corporation announced delayed 10-Q filingOn 08/17/2022, MusclePharm Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Sep 29FitLife Brands, Inc. (NasdaqCM:FTLF) entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.FitLife Brands, Inc. (NasdaqCM:FTLF) entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million on September 5, 2023. The Purchase Price is subject to adjustment and is expected to be funded from available cash and the proceeds from a committed $10.0 million term loan from First Citizens Bank with an interest rate equal to the SOFR (secured overnight financing rate) plus 275 basis points. On September 21, 2023, the U.S. Bankruptcy Court for the District of Nevada approved the transaction. Closing of the sale will occur on or before October 16, 2023. Samuel A. Schwartz of Schwartz Law, PLLC acted as legal advisor to MusclePharm. Todd Feinsmith of Troutman Pepper Hamilton Sanders LLP acted as legal advisor to FitLife Brands.
お知らせ • Sep 01Musclepharm Corporation Announces Resignation of Paul Karr as DirectorEffective as of August 9, 2023, Paul Karr resigned as director MusclePharm Corporation. Mr. Karr’s resignation from the Board of Directors of the Company did not result from any disagreement with the Company.
お知らせ • Jul 22Musclepharm Corporation Terminates Gary Shirshac as Chief Financial OfficerEffective as of July 10, 2023, MusclePharm Corporation terminated Chief Financial Officer, Gary Shirshac. There are no family relationships between Mr. Shirshac and any other director or officer of the Company. There are no transactions in which Mr. Shirshac has an interest requiring disclosure under Item 404(a) of Regulation S-K. Separately, on December 15, 2022, the Company filed for protection under Chapter 11 of the United States Bankruptcy Code before the United States Bankruptcy Court for the District of Nevada, Case No. 22-14422 – NMC. Attached hereto are copies of the Monthly Operating Reports filed in the bankruptcy case.
お知らせ • Dec 16MusclePharm Corporation Filed for BankruptcyMusclePharm Corporation filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Nevada on December 15, 2022. The debtor listed both its assets and liabilities in the range of $10 million to $50 million. The debtor is represented by Samuel A. Schwartz of Schwartz Law, PLLC as its legal counsel.
お知らせ • Sep 30MusclePharm Corporation Appoints Gary C. Shirshac to Serve as Interim Chief Financial OfficerOn September 26, 2022, MusclePharm Corporation appointed Gary C. Shirshac to serve as interim chief financial officer. There are no family relationships between Mr. Shirshac and any other director or officer of the company. There are no transactions in which Mr. Shirshac has an interest requiring disclosure under Item 404(a) of Regulation S-K. Set forth below is the biographical information of Mr. Shirshac, as required by Item 401 of Regulation S-K. Mr. Shirshac’s base salary is $250,000 and he will be eligible to participate in the company’s benefits plan as of October 1, 2022. Prior to joining the company, Mr. Shirshac, 60, served as the chief financial officer and on the board of Directors of Newpoint Financial Corporation from 2020 to February 2022. Prior to that, Mr. Shirshac served as the Chief Financial Officer and Managing Director of GCS Consulting from 2013 to 2019. Mr. Shirshac’s work experience prior to that included accounting, tax and SEC compliance work in-house, as a consultant and in national accounting firms. Mr. Shirshac is a Certified Public Accountant and received his BS Accountancy from Villanova University.
お知らせ • Aug 18MusclePharm Corporation announced delayed 10-Q filingOn 08/17/2022, MusclePharm Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jul 29+ 1 more updateMusclePharm Corporation Announces Appointment of Eric Chin as Chief Financial Officer of the CompanyMusclePharm Corporation announced that on July 28, 2022, the Board of Directors appointed Eric Chin as Chief Financial Officer of the Company. There are no family relationships between Mr. Chin and any other director or officer of the Company. Mr. Chin, joined the Company in June 2022 as Chief Accounting Officer. Prior to that, Mr. Chin served as the Chief Financial Officer of Apollo Medical Holdings Inc. from 2018 to May 2022. Prior to that, Mr. Chin served as the Controller/Head of Finance - Real Estate of Public Storage from 2015 to 2018. Mr. Chin served as Assistant Vice-President - Financial Reporting of Alexandria Real Estate Equities Inc. from 2011 to 2015. Mr. Chin began his career at Ernst & Young, LLP in 2002. Mr. Chin is a Certified Public Accountant and received his Bachelor of Arts in Business/Economics with Accounting and Computing from UCLA.
お知らせ • Jul 13+ 1 more updateSabina Rizvi Notifies MusclePharm Corporation of Her Resignation as President, Effective July 22, 2022On July 6, 2022, Sabina Rizvi notified the Board of Directors of MusclePharm Corporation of her resignation as President of the Company, effective July 22, 2022.
お知らせ • Jul 07MusclePharm Announces the Launch of FitMiss EnergyMusclePharm Corporation announced the launch of FitMiss Energy, a ready-to-drink, zero-calorie functional energy beverage featuring 450mg of Branched Chain Amino Acids (“BCAA”), 200mg of caffeine, and 100% recommended dietary intake (“RDI”) of Biotin per can in three refreshing flavors: Pineapple Coco, Mango Sunshine, and Watermelon Waterfall. The MusclePharm FitMiss brand has been a leader in the female performance segment, with FitMiss Delight, for the last 5 years. Building onto the FitMiss brand family, FitMiss Energy features no artificial colorings or flavorings and is available in competitively priced, 12-can cases of a single flavor or a variety-pack format exclusively on Amazon.
お知らせ • Jun 24Musclepharm Corporation Appoints Eric Chin as Chief Accounting OfficerMusclePharm Corporation announced that effective as of June 17, 2022 the company appointed Mr. Eric Chin as the Company’s Chief Accounting Officer. Mr. Chin, age 42, joins the Company from Apollo Medical Holdings Inc., where he served as Chief Financial Officer. From 2015 to 2018, Mr. Chin served as the Controller/Head of Finance - Real Estate of Public Storage. From 2011 to 2015, he served as Assistant Vice-President - Financial Reporting of Alexandria Real Estate Equities Inc. Mr. Chin began his career at Ernst & Young, LLP in 2002. Mr. Chin is a Certified Public Accountant. He received his Bachelor of Arts in Business/Economics with Accounting and Computing from UCLA.
お知らせ • Jun 15MusclePharm Corporation Appoints Sabina Rizvi as Member of the Board of DirectorsMusclePharm Corporation announced that effective June 10, 2022, the company appointed Sabina Rizvi, the Company’s President and Chief Financial Officer, as a member of the board of directors of the Company. Sabina Rizvi has served as the Company’s President and Chief Financial Officer since April 2021. Previously, Ms. Rizvi held multiple C-suite roles at Yum! Brands, with increasing responsibility including CFO of the Canadian and Thailand business units and President and General Manager of Pizza Hut Thailand, where she oversaw significant growth of the brand. Most recently, she was Chief Operating Officer, Yum! Digital and Technology, playing an instrumental role in leveraging technology to transform the customer experience. Ms. Rizvi graduated from University of Windsor, Canada with a Master of Business Administration and completed her Honors Bachelor of Mathematics from University of Waterloo, Canada. The Company believes Ms. Rizvi is qualified to serve as a member of the Company’s board of directors because of the aforementioned experience and the breadth of her management responsibilities with the Company.
お知らせ • May 12MusclePharm Corporation to Report Q1, 2022 Results on May 16, 2022MusclePharm Corporation announced that they will report Q1, 2022 results After-Market on May 16, 2022
お知らせ • Apr 13MusclePharm Corporation to Report Q4, 2021 Results on Apr 14, 2022MusclePharm Corporation announced that they will report Q4, 2021 results After-Market on Apr 14, 2022
お知らせ • Apr 01+ 1 more updateMusclePharm Corporation announced delayed annual 10-K filingOn 03/31/2022, MusclePharm Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Feb 08MusclePharm Rolls Out New and Improved MP Combat Protein Powder to Costco USMusclePharm Corporation announced the expansion of its product line with Costco U.S with the roll out of its reformulated MP Combat Protein Powder in a newly sized tub. The reformulated product has an improved taste and mixability factor and is now being sold in Costco U.S in a recyclable, 6.2-liter tub. The new product will be part of a promotion running in all Costco U.S stores this March with samples available for customers to try out the new taste.
お知らせ • May 18MusclePharm Corporation announced delayed 10-Q filingOn 05/17/2021, MusclePharm Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jan 22Musclepharm Appoints Michael Heller to Its Board of DirectorsMusclePharm Corporation announced that it has appointed Michael Heller to its Board of Directors. Michael Heller, Principal of Talent Resources Holdings, is a marketing visionary in the world of influencer, celebrity, athlete and social media marketing. He has become a leading industry voice, having appeared in such major outlets as CNBC, Business Insider, Fortune, Fox Business, Buzzfeed, CNN, Digiday, The Hollywood Reporter, Vanity Fair and many others. With over 25 years of experience, Michael has conceived and produced some of the most high-profile events and activations in the country, including the annual Sports Illustrated Super Bowl party.
お知らせ • Jan 09William Bush Submits Resignation from the Board of Directors of MusclePharm Corporation and All CommitteesOn December 31, 2020, William Bush submitted his resignation from the Board of Directors of MusclePharm Corporation and all committees on which he served, effective the date thereof.
